Clinical Trials

Carcinoma, Non-Small-Cell Lung

NCT05364645 2024-07-09

Testing the Use of Targeted Treatment for RET Positive Advanced Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT03190239 2024-02-28

XQonc-007

Advanced Non-squamous Non-small-cell Lung Cancer

NCT02531854 2023-12-19

A Study of Pemetrexed Maintenance With or Without ADXS11-001 Immunotherapy in Patients With Human Papillomavirus Positive (HPV+), NSCLC Following First-Line Induction Chemotherapy

Carcinoma, Non-Small-Cell Lung

NCT05791097 2023-07-24

AdvanTIG-306

Phase 3 Withdrawn

Carcinoma, Non-Small-Cell Lung

NCT02607423 2023-05-25

Fludeoxyglucose F-18 PET/CT in Predicting Response to Chemotherapy in Patients With Stage IIIA Non-small Cell Lung Cancer That Can Be Removed by Surgery

Carcinoma, Non-Small-Cell Lung

NCT03770299 2022-03-24

CheckMate 9TN

Carcinoma, Non-Small-Cell Lung

NCT02662634 2022-03-18

A Safety and Feasibility Study of AGS-003-LNG for the Treatment of Stage 3 Non Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

NCT04061590 2022-03-04

Pembrolizumab With or Without Chemotherapy Before Surgery in Treating Patients With Stage I-IIIA Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT04430933 2021-08-18

A Safety and Tolerability Study of NC318 in Combination With Chemotherapy for Subjects With Advanced or Metastatic NSCLC

Phase 1/2 Withdrawn

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

NCT04611776 2021-06-16

CATHAYA

Carcinoma, Non-Small-Cell Lung

NCT04203511 2020-06-09

INCMGA00012 in Combination With Chemoradiation in Participants With Stage III Non-Small Cell Lung Cancer (POD1UM-301)

Phase 3 Withdrawn

Carcinoma, Non-Small-Cell Lung

NCT03920839 2020-04-24

INCMGA00012 Plus Chemotherapy in Participants With Advanced Solid Tumors (POD1UM-105)

Parkinson Disease 4, Autosomal Dominant Lewy Body, Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung

NCT03498222 2020-02-25

iTRAP

Carcinoma, Non-Small-Cell Lung

NCT02947113 2017-11-30

HYPOLAN

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT02639767 2016-12-07

Concurrent Pemetrexed/Cisplatin With Pleural Intensity Modulated Radiation Therapy for Patients With Unresectable Malignant Pleural Mesothelioma

Mesothelioma, Malignant

NCT01928160 2015-07-13

Pemetrexed Disodium and Carboplatin or Cisplatin With or Without Erlotinib Hydrochloride in Treating Patient With Stage IV Non-Small Cell Lung Cancer Resistant to First-Line Therapy With Erlotinib Hydrochloride or Gefitinib

Carcinoma, Non-Small-Cell Lung

NCT01336543 2014-12-18

Consolidation Chemotherapy/Concurrent Chemo-radiotherapy for Inoperable Stage III Non-small Cell Lung Cancer (NSCLC)

Carcinoma, Non-Small-Cell Lung

NCT00668499 2014-05-21

A Study of VEGF-Antisense Oligonucleotide in Combination With Pemetrexed and Cisplatin for the Treatment of Advanced Malignant Mesothelioma

Phase 1/2 Withdrawn

Mesothelioma

NCT01836341 2013-12-19

Afatinib In Combination With Cisplatin Or Carboplatin + Pemetrexed In Patients With EGFR-Mutant Lung Cancers Undergoing Definitive Chemoradiation

Carcinoma, Non-Small-Cell Lung

NCT01674738 2013-10-11

SELECT-A

Carcinoma, Non-Small-Cell Lung

NCT01105390 2013-08-02

AMG 102, Pemetrexed Disodium, and Cisplatin in Treating Patients With Malignant Pleural Mesothelioma

Mesothelioma, Malignant, Solitary Fibrous Tumor, Pleural

NCT01416961 2012-08-22

Integration of Neutron Therapy in the Treatment Plan for Stage III Non-Small Cell Lung Cancer (NSCLC)

Lung Neoplasms

NCT01353482 2012-03-22

MESO-02

Phase 1/2 Withdrawn